Benjamin F. Edwards & Company’s Select Medical SEM Stock Holding History

Benjamin F. Edwards & Company’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-928	Closed	-$16K	–	1824
2023 Q2	$16K	Hold	928	–	–	﹤0.01%	1324
2023 Q1	$13K	Hold	928	–	–	﹤0.01%	1364
2022 Q4	$12K	Hold	928	–	–	﹤0.01%	1391
2022 Q3	$11K	Hold	928	–	–	﹤0.01%	1377
2022 Q2	$12K	Hold	928	–	–	﹤0.01%	1346
2022 Q1	$12K	Hold	928	–	–	﹤0.01%	1329
2021 Q4	$15K	Hold	928	–	–	﹤0.01%	1302
2021 Q3	$18K	Hold	928	–	–	﹤0.01%	1265
2021 Q2	$21K	Hold	928	–	–	﹤0.01%	1217
2021 Q1	$17K	Buy	+928	New	+$15.2K	﹤0.01%	1244

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Benjamin F. Edwards & Company's SEM Position: Q3 2023 in Review

Benjamin F. Edwards & Company sold out of Select Medical (SEM) in Q3 2023, closing a stake of 928 shares — an estimated $16K sold.

Benjamin F. Edwards & Company first reported a position in SEM in Q1 2021 and held it in 10 quarters. The position peaked at $21K in Q2 2021. 248 funds tracked by Wall St. Rank hold SEM as of Q3 2023.

Benjamin F. Edwards & Company reported no remaining Select Medical position as of Q3 2023 after selling out during the quarter.
Benjamin F. Edwards & Company sold 928 Select Medical shares in Q3 2023, an estimated $16K.
Benjamin F. Edwards & Company first reported a position in Select Medical in Q1 2021 and held it in 10 quarters.
Benjamin F. Edwards & Company's Select Medical position peaked at $21K in Q2 2021.
248 funds tracked by Wall St. Rank held Select Medical as of Q3 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2023, filed 13 Nov 2023.